Osteoporosis

Osteoporosis is a systemic skeletal disorder characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and a consequent increase in fracture risk. It is a "silent disease" often remaining undiagnosed until the first fragility fracture occurs.

Etiology involves a complex interplay of hormonal shifts (e.g., estrogen deficiency post-menopause), aging-related senescence of osteoblasts, vitamin D/calcium deficiency, and genetic predisposition. Polygenic variants (e.g., LRP5, ESR1 genes) influence bone mineral density (BMD) and peak bone mass attainment.

The fundamental mechanism is an imbalance in bone remodeling, where bone resorption by osteoclasts exceeds bone formation by osteoblasts. Increased levels of RANKL and decreased OPG lead to heightened osteoclast activity. This results in the loss of trabecular connectivity and thinning of cortical bone.

Affects over 200 million people globally. Prevalence increases significantly with age; women are disproportionately affected due to accelerated loss post-menopause.

Age, female sex, Caucasian/Asian ethnicity, low body weight, smoking, excessive alcohol, physical inactivity, glucocorticoid use, family history, and premature menopause.

A. Early Symptoms

• Asymptomatic B. Common Symptoms


• Back pain (from micro-fractures)


• Loss of height C. Advanced Symptoms


• Kyphosis (dowager's hump)


• Fragility fractures (hip, wrist, vertebrae) D. Emergency Symptoms


• Sudden severe localized pain post-fall


• Inability to bear weight


• Neurological deficits (e.g., spinal cord compression)

Inspection may reveal loss of height and exaggerated thoracic kyphosis. Palpation may detect spinal tenderness. Vital signs are typically normal.

A. Clinical Assessment: FRAX score calculation.
B. Laboratory Testing: Calcium, Vitamin D, PTH, TSH, alkaline phosphatase.
C. Imaging Studies: DXA scan.
D. Functional Tests: Gait and balance assessment.
E. Biopsy Findings: Rarely indicated; shows thinned trabeculae.
F. Genetic Testing: Not routinely performed.
G. Differential Diagnosis: Osteomalacia, multiple myeloma, hyperparathyroidism.

Test Name: Serum 25-hydroxyvitamin D
Type: Blood Test
Purpose: Assess bone health substrate.
Expected Findings: >30 ng/mL.
Interpretation: Low levels suggest impaired calcium absorption.

Dual-energy X-ray absorptiometry (DXA): Gold standard for BMD measurement. T-score ≤ -2.5 indicates osteoporosis.

Osteomalacia (defective mineralization), Multiple Myeloma (marrow infiltration), Metastatic bone disease.

Hip/vertebral fractures, chronic pain, decreased mobility, social isolation, and increased mortality.

A. Lifestyle Modifications: Weight-bearing exercise, smoking cessation.
B. Preventive Measures: Calcium and Vitamin D supplementation.
C. Medical Treatment: Bisphosphonates (Alendronate), RANKL inhibitors (Denosumab), PTH analogs (Teriparatide).
D. Surgical Treatment: Kyphoplasty/Vertebroplasty.
E. Interventional Procedures: Hip pinning.
F. Rehabilitation: Physical therapy for strengthening.
G. Emergency Management: Fracture stabilization, surgical fixation.

Prognosis depends on the occurrence of fractures. Hip fractures carry significant mortality and morbidity. Early treatment reduces fracture incidence by 30-50%.

Peak bone mass accumulation during youth, adequate dietary intake, fall prevention, and regular screening after age 65 (women) or 70 (men).

The following homeopathic remedies have been historically indicated for symptoms associated with Osteoporosis. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

📊 Osteoporosis Fracture Risk Assessment

Evaluates major osteoporotic fracture risk using age, weight, height, personal fracture history, and lifestyle factors.